|
Mr. Finkelstein is the Company's President and CEO and a member of the Board of Directors. He provides expertise in the creation, implementation, and financing of RegeneRx's business strategy. Mr. Finkelstein has been a chief executive officer and consultant in the bioscience industry for the past twenty-four years, having served as Chief Executive Officer of three biomedical companies since 1982, including as CEO of the Company from 1984 to 1989 and as Vice-Chairman from 1989 to 1991. He is experienced developing early-stage companies, has been responsible for the regulatory approval and marketing of a number of medical products in the U.S. and abroad, and has raised over $60 million in capital to finance these ventures. He currently serves on the boards of several bioscience firms, including the executive committees of the Technology Council of Maryland and MdBio, Inc., whose missions are to support bioscience development and education in the State of Maryland. Mr. Finkelstein received a business degree from the University of Texas where he majored in finance.
| 